GlassScriptPhysician profile
Colin Swenson
NPI 1902127723
$254,505.40
in general payments reported to CMS, 2019-2025
13 companies · $56K in 2025
The $56K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $26K · 2021: $17K · 2022: $27K · 2023: $53K · 2024: $31K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $114K · Travel and Lodging: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,775 · Food and Beverage: $2,937 · Honoraria: $2,600 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $113,685.25 |
| Travel and Lodging | $14,717.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,775.00 |
| Food and Beverage | $2,937.43 |
| Honoraria | $2,600.00 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $222,764.27 | 2019-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,236.05 | 2024-2025 | |
| Pharming Healthcare, INC. | $6,896.53 | 2024 | Joenja |
| Inogen, INC. | $5,819.81 | 2025 | Inogen Rove 6 |
| Baxter Healthcare | $5,660.08 | 2024-2025 | Hillrom - Volara System, Hillrom - Vest System Model 205 Acute Care, Hillrom - Metaneb System |
| Mannkind Corporation | $4,232.16 | 2024-2025 | |
| Electromed, INC. | $1,621.34 | 2021-2025 | Smartvest |
| Amgen INC. | $121.33 | 2023 | Tavneos |
| Verona Pharma, INC. | $110.84 | 2025 | Ohtuvayre |
| Csl Behring | $42.99 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Swenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.